Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs WOCKHARDT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES WOCKHARDT ZYDUS LIFESCIENCES/
WOCKHARDT
 
P/E (TTM) x 34.2 -15.8 - View Chart
P/BV x 5.8 2.5 229.2% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 ZYDUS LIFESCIENCES   WOCKHARDT
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-23
WOCKHARDT
Mar-23
ZYDUS LIFESCIENCES/
WOCKHARDT
5-Yr Chart
Click to enlarge
High Rs495316 156.9%   
Low Rs319145 219.7%   
Sales per share (Unadj.) Rs170.3184.0 92.6%  
Earnings per share (Unadj.) Rs19.8-43.1 -45.9%  
Cash flow per share (Unadj.) Rs26.9-25.7 -104.8%  
Dividends per share (Unadj.) Rs6.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs173.0231.7 74.7%  
Shares outstanding (eoy) m1,012.20144.09 702.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.41.3 190.9%   
Avg P/E ratio x20.6-5.3 -385.1%  
P/CF ratio (eoy) x15.1-9.0 -168.6%  
Price / Book Value ratio x2.41.0 236.6%  
Dividend payout %30.30-   
Avg Mkt Cap Rs m412,14433,202 1,241.3%   
No. of employees `000NANA-   
Total wages/salary Rs m24,5646,370 385.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m172,37426,510 650.2%  
Other income Rs m4,7461,220 389.0%   
Total revenues Rs m177,12027,730 638.7%   
Gross profit Rs m29,677-1,930 -1,537.7%  
Depreciation Rs m7,2272,510 287.9%   
Interest Rs m1,2993,020 43.0%   
Profit before tax Rs m25,897-6,240 -415.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,878-30 -19,593.3%   
Profit after tax Rs m20,019-6,210 -322.4%  
Gross profit margin %17.2-7.3 -236.5%  
Effective tax rate %22.70.5 4,721.1%   
Net profit margin %11.6-23.4 -49.6%  
BALANCE SHEET DATA
Current assets Rs m100,08219,140 522.9%   
Current liabilities Rs m55,26734,350 160.9%   
Net working cap to sales %26.0-57.4 -45.3%  
Current ratio x1.80.6 325.0%  
Inventory Days Days5039 127.7%  
Debtors Days Days9411 852.3%  
Net fixed assets Rs m144,77648,670 297.5%   
Share capital Rs m1,012720 140.6%   
"Free" reserves Rs m174,14632,660 533.2%   
Net worth Rs m175,15833,380 524.7%   
Long term debt Rs m02,240 0.0%   
Total assets Rs m244,94070,750 346.2%  
Interest coverage x20.9-1.1 -1,963.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.70.4 187.8%   
Return on assets %8.7-4.5 -193.0%  
Return on equity %11.4-18.6 -61.4%  
Return on capital %15.5-9.0 -171.8%  
Exports to sales %39.20-   
Imports to sales %11.93.5 343.4%   
Exports (fob) Rs m67,577NA-   
Imports (cif) Rs m20,544920 2,233.0%   
Fx inflow Rs m67,577730 9,257.1%   
Fx outflow Rs m20,544920 2,233.0%   
Net fx Rs m47,033-190 -24,754.2%   
CASH FLOW
From Operations Rs m26,8881,530 1,757.4%  
From Investments Rs m11,712-1,250 -937.0%  
From Financial Activity Rs m-44,004-3,150 1,397.0%  
Net Cashflow Rs m-5,338-2,800 190.6%  

Share Holding

Indian Promoters % 75.0 54.9 136.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.0 4.5 402.5%  
FIIs % 5.0 4.2 119.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 45.1 55.5%  
Shareholders   306,495 161,813 189.4%  
Pledged promoter(s) holding % 0.0 74.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    MANKIND PHARMA    


More on Cadila Healthcare vs Wockhardt

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Wockhardt Share Price Performance

Period Cadila Healthcare Wockhardt S&P BSE HEALTHCARE
1-Day 0.57% 4.99% 1.18%
1-Month 7.77% 0.15% -0.75%
1-Year 107.52% 290.07% 61.82%
3-Year CAGR 32.30% 13.79% 18.16%
5-Year CAGR 24.52% 7.92% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Wockhardt share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Wockhardt the stake stands at 54.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Wockhardt.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 30.3%.

Wockhardt paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Wockhardt.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.